查看購物車
  • Simplified Chinese
  • English
  • Japanese
肱骨外上髁炎治療市場規模、佔有率及成長分析（按治療方法、最終用戶和地區分類）－2026-2033年產業預測
市場調查報告書
商品編碼
1914022

肱骨外上髁炎治療市場規模、佔有率及成長分析（按治療方法、最終用戶和地區分類）－2026-2033年產業預測

Lateral Epicondylitis Treatment Market Size, Share, and Growth Analysis, By Treatment Type (Non-Surgical Treatments, Surgical Treatments), By End User (Hospitals, Specialty Clinics), By Region - Industry Forecast 2026-2033.
出版日期: | 出版商: SkyQuest | 英文 172 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

全球外側肘關節症候群治療市場規模預計在 2024 年達到 12.5 億美元，從 2025 年的 13 億美元成長到 2033 年的 18.1 億美元，在預測期（2026-2033 年）內複合年成長率為 4.2%。

由於重複性勞損的發生率不斷上升，尤其是在運動員、體力勞動者和上班族中，全球肱骨外上髁炎治療市場正經歷顯著成長。微創治療方法（例如富血小板血漿注射和衝擊波療法）的出現，拓展了治療選擇，同時人們對預防措施的認知也不斷提高。此外，再生醫學的進步和門診手術中心的普及，也改善了患者獲得治療的機會。人口老化以及人們對早期療育益處的認知不斷提高，進一步推動了市場擴張。在持續成長的需求背景下，肱骨外上髁炎的治療方案正變得越來越多樣化，也越來越容易獲得。

全球肱骨外上髁炎治療市場促進因素

肱骨外上髁炎在運動員、體力勞動者和上班族的發生率不斷上升，這主要是由於重複性動作活動的頻率增加所致，也是推動市場成長的因素。病例激增導致人們對各種治療方案的需求增加，從矯正器具和物理治療等非手術干預到關節鏡等外科手術。這一趨勢在已開發地區尤其明顯，這些地區積極老化日益受到重視，進一步推動了對有效治療方法的需求，以控制和緩解這種疾病。

限制全球肱骨外上髁炎治療市場的因素

全球肱骨外上髁炎治療市場面臨嚴峻挑戰，主要原因是富血小板血漿（PRP）療法、幹細胞療法和衝擊波療法等生物療法高成本。這些先進的治療方法通常不在醫療保險範圍內，尤其是在發展中地區，這對尋求有效治療的患者造成了經濟障礙。因此，許多患者可能會選擇價格較低的非生物療法（例如皮質類固醇注射），這可能會阻礙創新治療方法在市場上的廣泛應用，並限制肱骨外上髁炎的整體治療選擇。

全球肱骨外上髁炎治療市場趨勢

全球肱骨外上髁炎治療市場正經歷著向再生醫學的顯著轉變，其特點是富血小板血漿（PRP）療法、幹細胞注射和基於生長因子的療法等生物療法的接受度不斷提高。這些創新療法因其能夠促進組織自然修復並降低復發風險而備受關注，並成為傳統治療方法的更佳替代方案。這一趨勢在北美和歐洲尤為明顯，這些地區的醫療保健系統開始認可並支持整合這些先進治療方法，反映出醫療機構致力於改善肌腱疾病患者的治療效果。

目錄

介紹

  • 調查目標
  • 調查範圍
  • 定義

調查方法

  • 資訊收集
  • 二手資料和一手資料方法
  • 市場規模預測
  • 市場假設與限制

執行摘要

  • 全球市場展望
  • 供需趨勢分析
  • 細分市場機會分析

市場動態與展望

  • 市場規模
  • 市場動態
    • 促進因素和機遇
    • 限制與挑戰
  • 波特分析

關鍵市場考察

  • 關鍵成功因素
  • 競爭程度
  • 關鍵投資機會
  • 市場生態系統
  • 市場吸引力指數（2025）
  • PESTEL 分析
  • 總體經濟指標
  • 價值鏈分析
  • 定價分析
  • 案例研究
  • 顧客購買行為分析

全球肱骨外上髁炎治療市場規模：依治療方法及複合年成長率（2026-2033 年）分類

  • 非手術治療方法
    • 藥物治療
    • 物理治療
    • 矯正器具和支架
    • 其他非手術治療方法
  • 手術治療方法
    • 關節鏡手術
    • 開放性手術
    • 其他治療方法

全球肱骨外上髁炎治療市場規模（按年齡層分類）及複合年成長率（2026-2033 年）

  • 兒童
  • 成人版
  • 老年人

全球肱骨外上髁炎治療市場規模（按最終用戶分類）及複合年成長率（2026-2033 年）

  • 醫院
  • 專科診所
  • 門診手術中心
  • 居家醫療環境

全球肱骨外上髁炎治療市場規模及複合年成長率（2026-2033）

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地區
  • 中東和非洲
    • 海灣合作理事會國家
    • 南非
    • 其他中東和非洲地區

競爭資訊

  • 前五大公司對比
  • 主要企業的市場定位（2025 年）
  • 主要市場參與者所採取的策略
  • 近期市場趨勢
  • 公司市佔率分析（2025 年）
  • 主要企業公司簡介
    • 公司詳情
    • 產品系列分析
    • 依業務板塊進行公司股票分析
    • 2023-2025年營收年比比較

主要企業簡介

  • Teikoku Pharma, Inc.
  • Kasiak Research Pvt. Ltd.
  • Molecular Pharmacology Limited
  • Chugai Pharmaceutical Co., Ltd.
  • Seikagaku Corporation
  • OMRON Corporation
  • BioMedical Life Systems, Inc.
  • Zynex, Inc.
  • EMS Physio Ltd.
  • DJO Global, Inc.
  • Beurer GmbH
  • 3M
  • AKSIGEN
  • BTL Corporate

結論與建議

簡介目錄
Product Code: SQMIG45N2126

Global Lateral Epicondylitis Treatment Market size was valued at USD 1.25 Billion in 2024 and is poised to grow from USD 1.3 Billion in 2025 to USD 1.81 Billion by 2033, growing at a CAGR of 4.2% during the forecast period (2026-2033).

The global market for lateral epicondylitis treatment is experiencing notable growth due to a rising incidence of repetitive strain injuries, particularly among athletes, manual laborers, and office workers. The availability of minimally invasive treatment options, such as PRP injections and shockwave therapy, is enhancing therapeutic choices while awareness of preventive measures is increasing. Furthermore, advancements in regenerative medicine and the proliferation of ambulatory surgical centers are improving access to care for affected individuals. The expanding elderly population, alongside a heightened recognition of the benefits of early intervention, is further driving market expansion. As demand continues to grow, the landscape of treatment options for lateral epicondylitis is becoming increasingly diverse and accessible.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Lateral Epicondylitis Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Lateral Epicondylitis Treatment Market Segments Analysis

Global Lateral Epicondylitis Treatment Market is segmented by Treatment Type, End User and region. Based on Treatment Type, the market is segmented into Non-Surgical Treatments and Surgical Treatments. Based on End User, the market is segmented into Hospitals, Specialty Clinics, Ambulatory Surgical Centres and Homecare Settings. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Lateral Epicondylitis Treatment Market

The rising prevalence of lateral epicondylitis among athletes, manual laborers, and office workers serves as a significant driver for the market, largely due to the growing frequency of repetitive motion activities. This surge in cases has led to a heightened demand for a variety of treatment options, encompassing non-surgical interventions such as braces and physiotherapy, as well as surgical procedures like arthroscopic release. The trend is particularly pronounced in developed regions where there is a notable focus on active aging populations, further propelling the need for effective treatments tailored to manage and alleviate this condition.

Restraints in the Global Lateral Epicondylitis Treatment Market

The Global Lateral Epicondylitis Treatment market faces significant challenges due to the high costs associated with biologic therapies such as platelet-rich plasma (PRP) and stem cell treatments, as well as shockwave therapies. These advanced treatment options are often not covered by insurance, particularly in lesser-developed regions, creating a financial obstacle for patients seeking effective care. As a result, many individuals may opt for more affordable, non-biologic alternatives, such as corticosteroid injections, which can impede the broader acceptance and application of these innovative therapies within the market, limiting overall treatment options for lateral epicondylitis.

Market Trends of the Global Lateral Epicondylitis Treatment Market

The Global Lateral Epicondylitis Treatment market is witnessing a notable shift towards regenerative medicine, characterized by the increasing acceptance of biologic therapies such as platelet-rich plasma (PRP) therapy, stem cell injections, and growth factor-based treatments. These innovative solutions are gaining traction due to their ability to enhance natural tissue repair and reduce the likelihood of recurrence, positioning them as preferable alternatives to traditional treatments. This trend is especially prominent in North America and Europe, where healthcare systems are beginning to recognize and support the integration of these advanced therapeutic modalities, reflecting a broader commitment to improving patient outcomes in tendinopathies.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2025
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Case Studies
  • Customer Buying Behavior Analysis

Global Lateral Epicondylitis Treatment Market Size by Treatment Type & CAGR (2026-2033)

  • Market Overview
  • Non-Surgical Treatments
    • Medications
    • Physical therapy
    • Orthotics and braces
    • Other non-surgical treatments
  • Surgical Treatments
    • Arthroscopic surgery
    • Open surgery
    • Other surgical treatments

Global Lateral Epicondylitis Treatment Market Size by Age Group & CAGR (2026-2033)

  • Market Overview
  • Pediatric
  • Adult
  • Geriatric

Global Lateral Epicondylitis Treatment Market Size by End User & CAGR (2026-2033)

  • Market Overview
  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centres
  • Homecare Settings

Global Lateral Epicondylitis Treatment Market Size & CAGR (2026-2033)

  • North America (Treatment Type, Age Group, End User)
    • US
    • Canada
  • Europe (Treatment Type, Age Group, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Treatment Type, Age Group, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Treatment Type, Age Group, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Treatment Type, Age Group, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • Teikoku Pharma, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Kasiak Research Pvt. Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Molecular Pharmacology Limited
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Chugai Pharmaceutical Co., Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Seikagaku Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • OMRON Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BioMedical Life Systems, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Zynex, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • EMS Physio Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • DJO Global, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Beurer GmbH
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • 3M
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AKSIGEN
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BTL Corporate
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations